Silverarc Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-643,636
| Closed | -$30.6M | – | 69 |
|
|
2025
Q3 | $30.6M | Sell |
643,636
-70,175
| -10% | -$3.4M | 4.42% | 6 |
|
|
2025
Q2 | $38.1M | Sell |
713,811
-6,181
| -0.9% | -$281K | 7.8% | 2 |
|
|
2025
Q1 | $29.1M | Sell |
719,992
-19,571
| -3% | -$830K | 6.09% | 4 |
|
|
2024
Q4 | $20.6M | Buy |
739,563
+99,723
| +16% | +$3.02M | 4.6% | 5 |
|
|
2024
Q3 | $18.4M | Buy |
639,840
+14,753
| +2% | +$385K | 4.14% | 6 |
|
|
2024
Q2 | $14.7M | Buy |
625,087
+225,138
| +56% | +$4.81M | 3.62% | 8 |
|
|
2024
Q1 | $10.1M | Buy |
399,949
+150,695
| +60% | +$3.62M | 2.83% | 12 |
|
|
2023
Q4 | $5.82M | Buy |
249,254
+217,918
| +695% | +$4.3M | 1.8% | 19 |
|
|
2023
Q3 | $1.58M | Sell |
31,336
-210,021
| -87% | -$9.78M | 0.59% | 51 |
|
|
2023
Q2 | $11.3M | Buy |
241,357
+38,796
| +19% | +$1.78M | 3.8% | 7 |
|
|
2023
Q1 | $7.75M | Buy |
202,561
+30,461
| +18% | +$1.36M | 3.48% | 7 |
|
|
2022
Q4 | $9.43M | Sell |
172,100
-127,900
| -43% | -$5.48M | 3.25% | 7 |
|
|
2022
Q3 | $10.2M | Buy |
300,000
+39,675
| +15% | +$607K | 4.33% | 5 |
|
|
2022
Q2 | $2.46M | Buy |
+260,325
| New | +$2.71M | 1.15% | 36 |
|
|
2021
Q3 | – | Sell |
-33,028
| Closed | -$819 | – | 83 |
|
|
2021
Q2 | $819 | Buy |
33,028
+1,028
| +3% | +$28.9K | 0.4% | 69 |
|
|
2021
Q1 | $928K | Sell |
32,000
-3,179
| -9% | -$96.2K | 0.52% | 55 |
|
|
2020
Q4 | $908K | Buy |
+35,179
| New | +$979K | 0.55% | 52 |
|
